Menu UF Health Home Menu
 

In the News

We invite you to learn more about the innovative efforts underway at the UF Diabetes Institute. Together, these important contributions strengthen our mission to improve the lives of all individuals impacted by this disease.

Atkinson-to-use

UF Diabetes Researcher Honored by JDRF

Mark A. Atkinson, director of the University of Florida Diabetes Institute, and Alberto Pugliese, M.D., head of the Immunogenetics Program at the University of Miami's Diabetes Research Institute, were recently honored with the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award on behalf of the JDRF Network for Pancreatic Organ Donors with Diabetes (nPOD). Learn more.

Cusi

Researchers unravel complicated relationship between diabetes and HCV

Kenneth Cusi, M.D., F.A.C.P., F.A.C.E., Chief of Division of Adult Endocrinology, Diabetes, and Metabolism at the University of Florida, is featured in the January print issue of Endocrine Today for research related to the underlying links between diabetes and liver disease. The cover story focuses on the complicated relationship between diabetes and hepatitis C virus. Read more.

Walgreens

UF T1D research among JDRF’s Top 10 Research Advances in 2014

A collaborative type 1 diabetes study led by researchers from UF and the Institute of Diabetes Research, Helmholtz Zentrum Munchen, in Germany is recognized among JDRF's Top 10 Research Advances in 2014. The JDRF-funded research has shed more light on the connection between T1D, gut bacteria interactions, and certain viruses. Learn more.

Schatz-slider

American Diabetes Association Announces 2015 Board of Directors

UF Health Type 1 diabetes expert Desmond Schatz, M.D. has been elected to the American Diabetes Association's Board of Directors for 2015. Dr. Schatz has been a volunteer for the ADA for more than 25 years and has served on numerous committees. Dr. Schatz previously served on the national Board of Directors and was recently named president-elect of the American Diabetes Association, the nation's largest and leading voluntary health organization leading the fight to Stop Diabetes®, beginning in 2016.

ben

$1.5 million grant targets immune cell therapies in Type 1 diabetes

Benjamin Keselowsky, Ph.D. recently received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.

Haller-Michael_2907_Kiewel

Unlocking a combination treatment for T1D

Results from a recent UF Health pilot clinical study led by pediatric endocrinologist Michael Haller, M.D. have led to a new national trial investigating a combination therapy approach for treating new-onset type 1 diabetes patients.

Head Shot (2)

UF Diabetes Expert Speaks at National Continuing Education Conference

Ashby Walker, Ph.D., research assistant professor in the Department of Health Outcomes and Policy, recently presented at a national conference for nurse educators and physicians in Tampa, Fla., to discuss a recent UF photo research project, in which children with Type 1 diabetes were prompted to take and explain five pictures that captured what diabetes meant to them. The photos and explanations provide valuable perspectives and highlight the differences in disease experiences based on gender and socioeconomic status.

stabler-news

Nationally-recognized T1D biomedical engineer joins UF Diabetes Institute

Cherie Stabler, Ph.D., of the University of Florida College of Engineering, together with her team, were recently awarded a $4.9 million grant to engineer a microchip that will serve to house islets that produce beta cells. Her team hopes to use the microchips to improve the current amount of islets available to transplant into patients with diabetes, as well as screen pharmaceuticals and create beta cells from stem cells.

otsp-placeholder

On the Same Page: The UF Diabetes Institute

In the latest issue of On the Same Page, UF Health president David S. Guzick, M.D. Ph.D. details the events leading up to the formation of the new UF Diabetes Institute — a collaboration of dozens of researchers campuswide all focused on forging new advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians.

PicMonkey Collage

The University of Florida Diabetes Institute

Together, UF and UF Health are moving forward as national leaders in diabetes research, patient care, and innovation. Learn about the latest system-wide effort toward a collaborative approach toward the research and treatment of this disease.

Do-I-Qualify

ADA position statement addresses diabetes in child care setting

Type 1 diabetes care for children aged 5 years or younger requires unique management, according to a recent position statement in Diabetes Care. Authors stress that pediatric diabetes patients need a proactive disease care plan that involves clinicians, parents/guardians and child care staff. Researchers also highlighted hurdles in pediatric diabetes care, including language barriers, health literacy and ethnic and cultural practices.

Bill Nelson

UF diabetes and aging study recognized by U.S. Senator

U.S. Senator Bill Nelson, D-FL took note of a recent UF study authored by affiliate diabetes investigator Todd Manini, Ph.D. which highlights a link between sitting and risk for diabetes. "We must continue funding groundbreaking research like that at the University of Florida and promoting the kinds of lifestyle changes that will reduce the risks of diseases like diabetes in old age," he said.

submit-review

UF Health Pediatric Diabetes Endocrinology Program Ranks 14th Nationally

In its 2014-2015 Best Children’s Hospitals ratings, U.S. News & World Report ranked the UF Health Pediatric Diabetes and Endocrinology Program highest among pediatric program offerings at UF Health. The program also earned the highest-ratings among pediatric diabetes and endocrinology programs in Florida, and ranked 14th nationally.

3771A0CF-621F-43EC-8ECF10B11FF7B88B

Celiac screening for kids with type 1 diabetes

Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge.


2014

2013

2012

2011

2010

2000s